When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
10x Genomics ( NASDAQ: TXG ) is trading 10% higher after the company posted better-than-expected Q4 result, helped by higher consumables revenue in the Americas and EMEA.
Q4 GAAP EPS of -$0.15 beat by $0.17, while revenue of $156.2M (+8.9% Y/Y) beats by $8.03M.
Gross margin was 76% for the fourth quarter, as compared to 81%, a year earlier.
10x Genomics expects full year 2023 revenue to be in the range of $580M to $600M vs $596.51M consensus, representing 12% to 16% growth over full year 2022 revenue.